Remove CBD Remove Retail Remove THC
article thumbnail

Georgia: Regulators Finally License Retailers to Begin Selling Low-THC Cannabis Products to Authorized Patients

NORML

"For almost ten years, patients and their providers have lacked the ability to locally access these medically necessary state-approved products from state-licensed retailers. The post Georgia: Regulators Finally License Retailers to Begin Selling Low-THC Cannabis Products to Authorized Patients appeared first on NORML.

Retail 224
article thumbnail

Maine: Governor Signs Legislation Finalizing Rules for Retail Marijuana Sales

NORML

Janet Mills on Thursday signed legislation finalizing regulations governing the licensed production and retail sale of cannabis to adults. With the passage of the new rules, it is estimated that marijuana retailers may be operational by March 2020. Retailers will not be permitted to sell customers more than 2.5 Democratic Gov.

Retail 209
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Sends Warning Letters to Multiple Companies for Illegally Marketing CBD Products

NORML

Representatives of the US Food and Drug Administration issued warning letters on Monday to multiple companies for marketing CBD-specific products in ways that violate federal law. Currently, commercially available CBD products are not regulated by the FDA, despite the fact that some three in four Americans presume otherwise.

CBD 253
article thumbnail

NORML Submits Comments to FDA Ahead of CBD Hearing

NORML

NORML has submitted written comments to the US Food and Drug Administration ahead of the agency’s scheduled hearing on the regulation CBD-infused products. Currently, commercially marketed CBD-infused products are not subject to explicit federal regulations.

CBD 240
article thumbnail

FDA Hearing On ‘Hemp-Derived CBD’ Today

NORML

Washington, DC : Today the US Food and Drug Administration is taking in-person public testimony with regard to the “manufacturing, product quality, marketing, labeling, and sale” of CBD-infused retail products. ” Currently, commercially marketed CBD-infused products are not subject to explicit federal regulations.

Hemp 235
article thumbnail

Associated Press: Many Commercially Marketed CBD Products Tainted With Psychoactive Adulterants

NORML

One-third of commercially marketed CBD products tested positive for the presence of synthetic, psychoactive adulterants while others tested negative for any presence of cannabidiol, according to an investigation by the Associated Press. Not a single product tested contained the precise amount of CBD that was advertised on the packaging.

CBD 192
article thumbnail

Enforcement Bulletin – Prohibited: conversion of CBD to delta-8 THC; purchase or sale of hemp-derived delta-8 THC

Cannabis Law Report

Subject: Prohibited: conversion of CBD to delta-8 THC; purchase or sale of hemp-derived delta-8 THC. This bulletin is offered in response to stakeholders who have requested additional guidance regarding delta-8 THC following the release of LCB Policy Statement #PS21-01 on April 28, 2021. Enforcement Bulletin 21-03.

THC 107